Picture of Laboratorios Farmaceuticos Rovi logo

ROVI — Laboratorios Farmaceuticos Rovi News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Rovi Expects Its Operating Revenue To Decrease By Mid-Single-Digit Percentage Vs 2023

May 8 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * IN 2024, ROVI EXPECTS ITS OPERATING REVENUE TO DECREASE BY
A
MID-SINGLE-DIGIT PERCENTAGE IN COMPARISON WITH 2023 


Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Laboratorios Farmaceuticos Rovi

See all news